Keywords
Last Name
Institution

Florian Krammer

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentMicrobiology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Krammer F, Palese P. Universal influenza virus vaccines: need for clinical trials. Nat Immunol. 2013 Dec 18; 15(1):3-5.
      View in: PubMed
    2. Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, Bouvier NM. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun. 2013 Dec 10; 4:2854.
      View in: PubMed
    3. Klausberger M, Wilde M, Palmberger D, Hai R, Albrecht RA, Margine I, Hirsh A, García-Sastre A, Grabherr R, Krammer F. One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge. Vaccine. 2014 Jan 9; 32(3):355-62.
      View in: PubMed
    4. Margine I, Palese P, Krammer F. Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System. J Vis Exp. 2013; (81).
      View in: PubMed
    5. Goff PH, Eggink D, Seibert CW, Hai R, Martínez-Gil L, Krammer F, Palese P. Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies. PLoS One. 2013; 8(11):e79194.
      View in: PubMed
    6. Krammer F, Cox RJ. The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines. Expert Rev Vaccines. 2013 Dec; 12(12):1369-72.
      View in: PubMed
    7. Krammer F, Palese P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr Opin Virol. 2013 Oct; 3(5):521-30.
      View in: PubMed
    8. Ramos I, Krammer F, Hai R, Aguilera D, Bernal-Rubio D, Steel J, García-Sastre A, Fernandez-Sesma A. H7N9 influenza viruses interact preferentially with a2,3-linked sialic acids and bind weakly to a2,6-linked sialic acids. J Gen Virol. 2013 Nov; 94(Pt 11):2417-23.
      View in: PubMed
    9. Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med. 2013 Aug 14; 5(198):198ra107.
      View in: PubMed
    10. Margine I, Krammer F, Hai R, Heaton NS, Tan GS, Andrews SA, Runstadler JA, Wilson PC, Albrecht RA, García-Sastre A, Palese P. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. J Virol. 2013 Oct; 87(19):10435-46.
      View in: PubMed
    11. Seibert CW, Rahmat S, Krause JC, Eggink D, Albrecht RA, Goff PH, Krammer F, Duty JA, Bouvier NM, García-Sastre A, Palese P. Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs. J Virol. 2013 Jul; 87(14):7793-804.
      View in: PubMed
    12. Goff PH, Krammer F, Hai R, Seibert CW, Margine I, García-Sastre A, Palese P. Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol. 2013 Jul; 87(14):8235-40.
      View in: PubMed
    13. Krammer F, Pica N, Hai R, Margine I, Palese P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J Virol. 2013 Jun; 87(12):6542-50.
      View in: PubMed
    14. Sangster MY, Baer J, Santiago FW, Fitzgerald T, Ilyushina NA, Sundararajan A, Henn AD, Krammer F, Yang H, Luke CJ, Zand MS, Wright PF, Treanor JJ, Topham DJ, Subbarao K. B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination. Clin Vaccine Immunol. 2013 Jun; 20(6):867-76.
      View in: PubMed
    15. Gerster P, Kopecky EM, Hammerschmidt N, Klausberger M, Krammer F, Grabherr R, Mersich C, Urbas L, Kramberger P, Paril T, Schreiner M, Nöbauer K, Razzazi-Fazeli E, Jungbauer A. Purification of infective baculoviruses by monoliths. J Chromatogr A. 2013 May 17; 1290:36-45.
      View in: PubMed
    16. Margine I, Hai R, Albrecht RA, Obermoser G, Harrod AC, Banchereau J, Palucka K, García-Sastre A, Palese P, Treanor JJ, Krammer F. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J Virol. 2013 Apr; 87(8):4728-37.
      View in: PubMed
    17. Margine I, Martinez-Gil L, Chou YY, Krammer F. Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity. PLoS One. 2012; 7(12):e51559.
      View in: PubMed
    18. Miller MS, Tsibane T, Krammer F, Hai R, Rahmat S, Basler CF, Palese P. 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. J Infect Dis. 2013 Jan 1; 207(1):98-105.
      View in: PubMed
    19. Krammer F, Margine I, Tan GS, Pica N, Krause JC, Palese P. A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. PLoS One. 2012; 7(8):e43603.
      View in: PubMed
    20. Krammer F, Pica N, Hai R, Tan GS, Palese P. Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice. J Virol. 2012 Oct; 86(19):10302-7.
      View in: PubMed
    21. Pica N, Langlois RA, Krammer F, Margine I, Palese P. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. J Virol. 2012 Oct; 86(19):10293-301.
      View in: PubMed
    22. Leyva-Grado VH, Mubareka S, Krammer F, Cárdenas WB, Palese P. Influenza virus infection in guinea pigs raised as livestock, Ecuador. Emerg Infect Dis. 2012 Jul; 18(7):1135-8.
      View in: PubMed
    23. Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, Palese P. A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol. 2012 Jun; 86(11):6179-88.
      View in: PubMed
    24. Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, Margine I, Albrecht RA, Palese P. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol. 2012 May; 86(10):5774-81.
      View in: PubMed
    25. Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, García-Sastre A, Palese P. Attenuated influenza virus construct with enhanced hemagglutinin protein expression. J Virol. 2012 May; 86(10):5782-90.
      View in: PubMed
    26. Seibert CW, Rahmat S, Krammer F, Palese P, Bouvier NM. Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance. J Virol. 2012 May; 86(9):5386-9.
      View in: PubMed
    27. Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, García-Sastre A, Palese P. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A. 2012 Feb 14; 109(7):2573-8.
      View in: PubMed
    28. Palmberger D, Rendic D, Tauber P, Krammer F, Wilson IB, Grabherr R. Insect cells for antibody production: evaluation of an efficient alternative. J Biotechnol. 2011 May 20; 153(3-4):160-6.
      View in: PubMed
    29. Krammer F, Pontiller J, Tauer C, Palmberger D, Maccani A, Baumann M, Grabherr R. Evaluation of the influenza A replicon for transient expression of recombinant proteins in mammalian cells. PLoS One. 2010; 5(10):e13265.
      View in: PubMed
    30. Krammer F, Schinko T, Palmberger D, Tauer C, Messner P, Grabherr R. Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol. 2010 Jul; 45(3):226-34.
      View in: PubMed
    31. Krammer F, Grabherr R. Alternative influenza vaccines made by insect cells. Trends Mol Med. 2010 Jul; 16(7):313-20.
      View in: PubMed
    32. Krammer F, Schinko T, Messner P, Palmberger D, Ferko B, Grabherr R. Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis. J Virol Methods. 2010 Jul; 167(1):17-22.
      View in: PubMed
    33. Krammer F, Nakowitsch S, Messner P, Palmberger D, Ferko B, Grabherr R. Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice. Biotechnol J. 2010 Jan; 5(1):17-23.
      View in: PubMed
    34. Finkelstein M, Liss GM, Krammer F, Kusiak RA. Mortality among workers receiving compensation awards for silicosis in Ontario 1940-85. Br J Ind Med. 1987 Sep; 44(9):588-94.
      View in: PubMed
    35. Krammer F. [Therapy of hypotension in the framework of balneotherapy]. Hippokrates. 1968 Dec 31; 39(24):933-6.
      View in: PubMed
    36. Krammer F. [The mineral springs in Italy]. Arch Phys Ther (Leipz). 1967 Jan-Feb; 19(1):7-10.
      View in: PubMed
    37. Krammer F. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin]. Med Welt. 1966 Jul 9; 28:1524-8.
      View in: PubMed
    38. Krammer F. [The balneotherapy of gout]. Wien Med Wochenschr. 1966 Jul 9; 116(28):625-9.
      View in: PubMed
    39. Krammer F. [Pain and painful sensation from the balneological viewpoint]. Arch Phys Ther (Leipz). 1966 Jul-Aug; 18(4):365-9.
      View in: PubMed
    40. KRAMMER F. [ALLERGIC RHEUMATISM]. Hippokrates. 1965 Apr 30; 36:304-10.
      View in: PubMed
    41. KRAMMER F. [GEOLOGIC AND CHEMICAL CONDITIONS OF THE SCHALLERBACHER RIESENTHERME AND ITS MEDICAL SIGNIFICANCE]. Arch Phys Ther (Leipz). 1964 Jul-Aug; 16:257-64.
      View in: PubMed
    42. KRAMMER F. [BALNEOTHERAPY IN ITS FUTURE ASPECTS]. Arch Phys Ther (Leipz). 1963 Sep-Oct; 15:351-7.
      View in: PubMed
    43. KRAMMER F. [BALNEOTHERAPY OF SKIN DISEASES]. Arch Phys Ther (Leipz). 1963 May-Jun; 15:161-9.
      View in: PubMed
    44. KRAMMER F. [The significance of percutaneous treatment in the course of the therapy of rheumatic diseases]. Wien Med Wochenschr. 1963 Feb 9; 113:134-6.
      View in: PubMed
    45. KRAMMER F. [Modern therapy of osteoporosis]. Z Rheumaforsch. 1962 Oct; 21:383-91.
      View in: PubMed
    46. KRAMMER F. [Balneological treatment of chronic nerve diseases in a sulfur bath]. Arch Phys Ther (Leipz). 1962 Jul-Aug; 14:335-42.
      View in: PubMed
    47. KRAMMER F. [The significance of Niamide in the treatment of rheumatic diseases]. Wien Med Wochenschr. 1961 May 27; 111:353-5.
      View in: PubMed
    48. KRAMMER F. [Combined therapy of psoriasis with sulfur baths of the Bad Schallerbach spa and with espritin]. Wien Med Wochenschr. 1961 Jan 28; 111:77-80.
      View in: PubMed
    49. KRAMMER F. [The aging man in the health resort]. Arch Phys Ther (Leipz). 1959 Sep-Oct; 11:372-7.
      View in: PubMed
    50. KRAMMER F. [Diencephalic disorders and rheumatism]. Z Rheumaforsch. 1959 Feb; 18(1-2):42-8.
      View in: PubMed
    51. KRAMMER F. [Stimulation of calorific nerves by skin stimulating substance as adjuvant of balneotherapy of rheumatic diseases]. Wien Med Wochenschr. 1958 Aug 2; 108(31):654-5.
      View in: PubMed
    52. KRAMMER F. [Total balneotherapy in the prevention of hazards of civilization]. Arch Phys Ther (Leipz). 1957 May-Jun; 9(3):263-8.
      View in: PubMed
    53. KRAMMER F. [Experiences with additional iromine medication in the treatment of various rheumatic diseases at the sulfur springs resort Bad Schallerbach]. Wien Med Wochenschr. 1957 Apr 20; 107(16):331-2.
      View in: PubMed
    54. KRAMMER F. [Principles of the treatment of cardiovascular diseases with sulfur medicinal bath with cardiofrik]. Wien Med Wochenschr. 1956 Apr 28; 106(17):382-4.
      View in: PubMed
    55. KRAMMER F. [Austria, the land of medical baths]. Dtsch Med J. 1955 Jul 15; 6(13-14):496-8.
      View in: PubMed
    56. KRAMMER F. [Steramin in treatment of rheumatic disease]. Wien Med Wochenschr. 1950 Aug 26; 100(31-2):544-5.
      View in: PubMed
    Krammer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067